We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62B
AUM Growth
+$4.39B
Cap. Flow
-$1.97B
Cap. Flow %
-3.18%
Top 10 Hldgs %
43.7%
Holding
1,103
New
130
Increased
284
Reduced
500
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$218M
2
PH icon
Parker-Hannifin
PH
+$155M
3
ILMN icon
Illumina
ILMN
+$80.7M
4
DIS icon
Walt Disney
DIS
+$74.2M
5
AZEK
The AZEK Co
AZEK
+$56.4M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$819M
2
META icon
Meta Platforms (Facebook)
META
+$338M
3
MSFT icon
Microsoft
MSFT
+$131M
4
AMZN icon
Amazon
AMZN
+$106M
5
CRM icon
Salesforce
CRM
+$93.2M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Communication Services 16.35%
3 Consumer Discretionary 16.22%
4 Healthcare 12.62%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTSI icon
101
MACOM Technology Solutions
MTSI
$23.7B
$58.2M 0.09%
888,780
-8,218
-0.9% -$498K
MGRC icon
102
McGrath RentCorp
MGRC
$2.92B
$55.1M 0.09%
595,412
+26,712
+5% +$2.44M
AIT icon
103
Applied Industrial Technologies
AIT
$13.3B
$52M 0.08%
359,298
-3,314
-0.9% -$442K
IBP icon
104
Installed Building Products
IBP
$6.49B
$51.9M 0.08%
370,454
+52,705
+17% +$6.21M
VEEV icon
105
Veeva Systems
VEEV
$37.4B
$51.1M 0.08%
258,553
-3,364
-1% -$614K
ENSG icon
106
The Ensign Group
ENSG
$10.7B
$49.4M 0.08%
517,268
-4,781
-0.9% -$450K
BOOT icon
107
Boot Barn
BOOT
$4.95B
$48.9M 0.08%
577,590
+7,898
+1% +$579K
COLM icon
108
Columbia Sportswear
COLM
$2.94B
$48.8M 0.08%
632,419
-12,232
-2% -$985K
WEX icon
109
WEX
WEX
$6.31B
$48.4M 0.08%
265,900
-10,679
-4% -$1.89M
WHD icon
110
Cactus
WHD
$5.44B
$48.1M 0.08%
1,135,696
-10,500
-0.9% -$409K
LTH icon
111
Life Time Group Holdings
LTH
$9.79B
$48M 0.08%
2,441,635
+393,478
+19% +$7.53M
SUPN icon
112
Supernus Pharmaceuticals
SUPN
$2.77B
$47.9M 0.08%
1,593,305
+33,243
+2% +$1.16M
XNCR icon
113
Xencor
XNCR
$1.55B
$47.7M 0.08%
1,908,358
-39,311
-2% -$1.07M
DRVN icon
114
Driven Brands
DRVN
$2.2B
$46.9M 0.08%
1,732,015
-29,403
-2% -$819K
EVTC icon
115
Evertec
EVTC
$1.78B
$46M 0.07%
1,249,293
-11,520
-0.9% -$399K
WNS
116
DELISTED
WNS Holdings
WNS
$45.8M 0.07%
621,706
-177,672
-22% -$14.2M
VCEL icon
117
Vericel Corp
VCEL
$2.31B
$45.6M 0.07%
1,214,415
-11,231
-0.9% -$369K
KAI icon
118
Kadant
KAI
$3.99B
$45M 0.07%
202,689
+6,967
+4% +$1.4M
MSCI icon
119
MSCI
MSCI
$40.9B
$44.5M 0.07%
94,882
-1,329
-1% -$648K
TCOM icon
120
Trip.com Group
TCOM
$29.1B
$44.3M 0.07%
1,266,729
-6,575
-0.5% -$229K
ATRC icon
121
AtriCure
ATRC
$2.11B
$43.8M 0.07%
887,399
-8,203
-0.9% -$378K
SOVO
122
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$43.6M 0.07%
2,229,236
+354,891
+19% +$6.4M
PTCT icon
123
PTC Therapeutics
PTCT
$6.12B
$43.2M 0.07%
1,061,398
-169,684
-14% -$8.3M
VNT icon
124
Vontier
VNT
$4.74B
$41.8M 0.07%
1,296,755
+85,943
+7% +$2.48M
SKX
125
DELISTED
Skechers
SKX
$41.8M 0.07%
792,837
+8,920
+1% +$457K

Similar funds

Loomis, Sayles & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Loomis, Sayles & Company held 1,103 positions worth $62B, up 7.6% from $57.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Loomis, Sayles & Company withdrew a net $1.97B in Q2 2023, closing 130 positions and reducing 500 holdings. Its most notable exit was Halozyme, an estimated $81.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in The AZEK Co worth $66.1M.

  • Loomis, Sayles & Company's largest Q2 2023 buy was The AZEK Co: 2,181,837 shares worth $66.1M.
  • Loomis, Sayles & Company added most to Tesla in Q2 2023, an estimated $218M increase.
  • Loomis, Sayles & Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $819M.
  • Loomis, Sayles & Company fully exited Halozyme in Q2 2023, selling an estimated $81.3M.
  • Loomis, Sayles & Company's ten largest holdings make up 44% of its $62B portfolio in Q2 2023.
  • Loomis, Sayles & Company opened 130 new positions and closed 130 in Q2 2023.
  • Loomis, Sayles & Company's portfolio value rose 7.6% quarter-over-quarter to $62B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.